Department of Pediatrics, State University of New York, Downstate Medical Center, Brooklyn, NY, USA.
Department of Ophthalmology, State University of New York, Downstate Medical Center, Brooklyn, NY, USA.
Pediatr Res. 2022 Jul;92(1):109-117. doi: 10.1038/s41390-021-01707-z. Epub 2021 Aug 28.
Preterm infants frequently experience intermittent hypoxia (IH) episodes, rendering them susceptible to oxidative stress and gut dysbiosis. We tested the hypothesis that early supplementation with antioxidants and/or fish oil promotes gut biodiversity and mitigates IH-induced gut injury.
Newborn rats were exposed to neonatal IH from birth (P0) to P14 during which they received daily oral supplementation with: (1) coenzyme Q10 (CoQ10) in olive oil, (2) fish oil, (3) glutathione nanoparticles (nGSH), (4) CoQ10 + fish oil, or (5) olive oil (placebo control). Pups were placed in room air (RA) from P14 to P21 with no further treatment. RA controls were similarly treated. Stool samples were assessed for microbiota and terminal ileum for histopathology and morphometry, total antioxidant capacity, lipid peroxidation, and biomarkers of gut injury.
Neonatal IH induced histopathologic changes consistent with necrotizing enterocolitis, which were associated with increased lipid peroxidation, toll-like receptor, transforming growth factor, and nuclear factor kappa B. Combination of CoQ10 + fish oil and nGSH were most effective for preserving gut integrity, reducing biomarkers of gut injury, and increasing commensal organisms.
Combination of antioxidants and fish oil may confer synergistic benefits to mitigate IH-induced injury in the terminal ileum.
Antioxidant and fish oil (PUFA) co-treatment was most beneficial for reducing neonatal IH-induced gut injury. The synergistic effects of antioxidant and fish oil is likely due to prevention of IH-induced ROS attack on lipids, thus preserving and augmenting its therapeutic benefits. Combination treatment was also effective for increasing the abundance of the non-pathogenic Firmicutes phylum, which is associated with a healthy gastrointestinal system of the newborn. Extremely low gestational age neonates who are at high risk for frequent, repetitive neonatal IH and oxidative stress-induced diseases may benefit from this combination therapy.
早产儿经常经历间歇性缺氧 (IH) 发作,使他们易受氧化应激和肠道菌群失调的影响。我们检验了这样一个假设,即早期补充抗氧化剂和/或鱼油可促进肠道生物多样性并减轻 IH 引起的肠道损伤。
从出生(P0)到 P14 期间,新生大鼠接受新生儿 IH 暴露,在此期间,它们每天接受口服补充剂:(1)橄榄油中的辅酶 Q10 (CoQ10),(2)鱼油,(3)谷胱甘肽纳米粒子 (nGSH),(4)CoQ10+鱼油,或(5)橄榄油(安慰剂对照)。从 P14 到 P21,幼崽被置于室内空气 (RA) 中,不再进行进一步治疗。RA 对照组接受类似治疗。评估粪便样本中的微生物群和回肠末端的组织病理学和形态计量学、总抗氧化能力、脂质过氧化和肠道损伤的生物标志物。
新生儿 IH 诱导的组织病理学变化与坏死性小肠结肠炎一致,这与脂质过氧化、Toll 样受体、转化生长因子和核因子 kappa B 的增加有关。CoQ10+鱼油和 nGSH 的组合最有效地维持肠道完整性,降低肠道损伤的生物标志物,并增加共生体。
抗氧化剂和鱼油的组合可能会协同发挥作用,减轻末端回肠中的 IH 诱导损伤。
抗氧化剂和鱼油 (PUFA) 的联合治疗对减轻新生儿 IH 引起的肠道损伤最有益。抗氧化剂和鱼油的协同作用可能是由于预防 IH 诱导的 ROS 攻击脂质,从而保持和增强其治疗效果。联合治疗还可有效增加非致病性厚壁菌门的丰度,这与新生儿健康的胃肠道系统有关。极早产儿的胎龄极低,他们经常面临反复发作的新生儿 IH 和氧化应激相关疾病的风险,可能受益于这种联合治疗。